• Skip to main content
  • Skip to header right navigation
  • Skip to after header navigation
  • Skip to site footer
  • Facebook
  • Instagram
  • Contact Us
  • Donate
  • Home
    • Newsletters
    • Personal Stories
    • Support Articles
  • Medical Information
    • Conferences
    • Grant Funding
  • Support CBTF
    • CBTF Board and Advisors
    • CBTF Sponsors & Partnerships
  • Home
  • Patients and Families
    • Childhood Brain Tumor Updates
    • Newsletters
    • Personal Stories
    • Support Articles
  • Medical Information
    • Childhood Brain Tumor Updates
  • Research
    • Conferences
    • Grant Funding
    • Research Links
  • Support CBTF
    • Geoff Cornman Memorial Golf Tournament
  • About CBTF
    • CBTF Board and Advisors
    • CBTF Sponsors & Partnerships

pediatric brain tumors

Germ Cell Tumors of the Brain

01/01/2020 by Jeanne Young

Jonathan L. Finlay, MB ChB, FRCP (Lond.), FRCPCH, Director, Neuro-oncology Program; Elizabeth and Richard Germain Endowed Professor of Pediatric Cancer, Division of Peduiatric Hematology, Oncology and Blood & Marrow Transplant, Nationwide Children’s Hospital. Professor of Pediatrics and Radiation Oncology, The Ohio State University, Columbus, Ohio, USA The family of tumors known as germ cell tumors …

Read moreGerm Cell Tumors of the Brain

Why Research is Important to Me

12/30/2019 by Jeanne Young

John Y.H. Kim, MD, Baylor College of Medicine, Houston, TX Pediatrics became the focus of my clinical interests because of its intrinsic orientation toward developmental issues. I have since had the great fortune of serving children and their families who have charged me with my life’s work. No group of patients and families appeared to …

Read moreWhy Research is Important to Me

Angiogenesis Inhibitors: A New Frontier in Cancer Therapy

12/17/2019 by Jeanne Young

Tobey J. MacDonald, M.D. For over 50 years, the field of cancer therapy has been dominated by the concept that the tumor must be the selected target of the chemotherapy delivered. Therefore, any drug with the ability to directly kill tumor cells in the laboratory was by definition a candidate for use as chemotherapy in …

Read moreAngiogenesis Inhibitors: A New Frontier in Cancer Therapy

Targeting H3.3 Mutations in Pediatric HGG

12/01/2019 by Jeanne Young

Brendan Price, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Pediatric high-grade gliomas (pHGG) have few treatment options and most children diagnosed only survive for 1-2 years. Identifying new treatments is therefore of the highest priority. Work in the lab is focused on understanding how these brain tumors arise, with the …

Read moreTargeting H3.3 Mutations in Pediatric HGG

Proton Therapy: A Treatment Option for Children with Brain Tumors

11/27/2019 by Jeanne Young

Hillary Bennett and Catherine M. Mannix, RN, BSN, OCN The diagnosis of a brain tumor is never welcome news for anyone.  But this type of cancer is especially problematic in children, as their developing nervous systems are particularly sensitive to the effects of radiation, a major form of treatment for brain and other solid pediatric …

Read moreProton Therapy: A Treatment Option for Children with Brain Tumors

Advances in Surgical Technique for Childhood Brain Tumors

11/22/2019 by Jeanne Young

Introduction I will divide advances in surgical technique over the past several decades into 4 major categories: greater visual magnification, improved aids to navigation, better functional brain mapping, and more precise tumor destruction. Magnification The operating neurosurgical microscope has been used since the 1950’s when Dr. RMP Donaghy of the University of Vermont was active …

Read moreAdvances in Surgical Technique for Childhood Brain Tumors

Successful Cancer Treatment Begins with an Accurate Pathology Diagnosis

12/01/2017 by Jeanne Young

Barry M. Shmookler, MD The first crucial step in cancer management is to assure that the pathology diagnosis (the biopsy) is correct and accurate. What is the basis for this statement? A pathologist is the only physician who can make the actual diagnosis of cancer. He/she is a medical doctor with a specialty training in the …

Read moreSuccessful Cancer Treatment Begins with an Accurate Pathology Diagnosis

MR Imaging of Brain Tumors

12/27/2016 by Jeanne Young

Recent Developments Gilbert Vezina, M.D., Director of Neuroradiology – Children’s National Medical Center, Washington D.C. Imaging techniques to diagnose, stage, and follow patients with brain tumors are central to their clinical management. Magnetic resonance imaging (MRI) is the most commonly utilized technique for lesion detection, definition of extent, detection of spread and in evaluation of …

Read moreMR Imaging of Brain Tumors

Functional Analysis of the H3.3‐K27M mutation in pediatric glioma

12/01/2014 by Jeanne Young

Marius Wernig, M.D., Ph.D. Stanford University School of Medicine The lysine 27 to methionine substitution in histone variant H3.3 (H3.3-K27M) is the most common mutation in pediatric high grade gliomas. Recent studies have demonstrated that this mutation leads to a global reduction of H3K27 trimethylation in a dominant manner by sequestering an enzymatic subunit of …

Read moreFunctional Analysis of the H3.3‐K27M mutation in pediatric glioma
  • Previous
  • Page 1
  • Page 2
  • Page 3
  • Next

The Childhood Brain Tumor Foundation

“Together, Reaching for a Cure”

301-515-2900 or 877-217-4166

CBTF Sponsors and Partners

Surgical Theater
FD Associates-CBTF Sponsor
Run with the Saints Houston, TX event

If you are interested in becoming a Sponsor or Partner of CBTF,

please contact us. Thank you!

  • Mail
  • Facebook
  • Instagram

Copyright © 2025 · The Childhood Brain Tumor Foundation · All Rights Reserved · Web Design by Wood WEB Worx